knowledge -WSS

knowledge

author：hotspot 2025-10-02 01:38:45 Page View：688

U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT — President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Massive project maps cells in human brain in unprecedented detail
Next article： In Memoriam: Notable people who died in 2023

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Physician assistants need a new name. Here's what it should be

AdobeI’mstandingoveranoperatingtable,excisingaskincancerfromtheforeheadofanelderlygentlemanwhilesoft

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Gene therapy denied for Afghan refugee whose father aided U.S.

ThePashaichildren(fromleft):Abubakar,Mohammad,andSufyan.Illustration:STAT;PhotoCourtesyOnasweltering